Search
ALK tyrosine kinase receptor; anaplastic lymphoma kinase; CD246 (ALK)
Function:
- receptor for pleiotrophin
- tyrosine-protein kinase activity
- role in the normal development & function of the nervous system
- phosphorylates almost exclusively at the 1st Tyr of the Y-x-x-x-Y-Y motif
Structure:
- homodimer.
- N-glycosylated
- belongs to the protein kinase superfamily, Tyr protein kinase family, insulin receptor subfamily
- contains 1 LDL-receptor class A domain
- contains 2 MAM domains
- contains 1 protein kinase domain
Compartment: membrane
Expression:
- expressed in brain & CNS
- expressed weakly in small intestine, colon, prostate & testis
Pathology:
- chromosomal translocation t(2;5)(p23;q35.1) involving ALK with NPM1 is found in a form of non-Hodgkin lymphoma
- chromosomal translocations t(2;11)(p23;p15) involving ALK with CARS & t(2;4)(p23;q21) involving ALK with SEC31A are associated with inflammatory myofibroblastic tumors
- chromosomal translocation t(2;17)(p23;q25) involving ALK with ALO17 is associated with anaplastic large-cell lymphoma
Related
anaplastic lymphoma kinase (ALK) antigen in tissue
anaplastic lymphoma kinase (ALK) gene rearrangement
General
cluster-of-differentiation antigen; cluster designation antigen; CD antigen
glycoprotein
tyrosine kinase receptor (RTK)
Properties
SIZE: entity length = 1620 aa
MW = 176 kD
COMPARTMENT: cellular membrane
STATE: active state
MOTIF: signal sequence {1-18}
N-glycosylation site {N169}
Ser phosphorylation site {S211}
N-glycosylation site {N244}
MAM domain {264-427}
MOTIF: cysteine residue {*1} (2)
MODIFICATION: cysteine residue {*2}
cysteine residue {*2} (2)
MODIFICATION: cysteine residue {*1}
N-glycosylation site {N285}
N-glycosylation site {N324}
N-glycosylation site {N411}
N-glycosylation site {N424}
LDL-receptor class A {437-473}
MOTIF: N-glycosylation site {N445}
MAM domain {478-636}
MOTIF: cysteine residue {*1} (2)
MODIFICATION: cysteine residue {*2}
cysteine residue {*2} (2)
MODIFICATION: cysteine residue {*1}
N-glycosylation site {N563}
N-glycosylation site {N571}
N-glycosylation site {N627}
N-glycosylation site {N709}
N-glycosylation site {N808}
glycine-rich region {816-940}
MOTIF: N-glycosylation site {N863}
N-glycosylation site {N864}
N-glycosylation site {N886}
N-glycosylation site {N986}
transmembrane domain {1039-1059}
Tyr phosphorylation site {Y1078}
Tyr phosphorylation site {Y1092}
Tyr phosphorylation site {Y1096}
kinase domain
SITE: 1116-1392
MOTIF: ATP-binding site
NAME: ATP-binding site
SITE: 1122-1130
Tyr phosphorylation site {Y1131}
ATP-binding site
NAME: ATP-binding site
SITE: 1150-1150
aspartate residue {D1249}
Tyr phosphorylation site {Y1278}
Tyr phosphorylation site {Y1282}
Tyr phosphorylation site {Y1283}
Tyr phosphorylation site {Y1359}
Tyr phosphorylation site {Y1507}
Tyr phosphorylation site {Y1584}
Tyr phosphorylation site {Y1604}
Database Correlations
OMIM 105590
MORBIDMAP 105590
UniProt Q9UM73
PFAM correlations
Entrez Gene 238
Kegg hsa:238
ENZYME 2.7.10.1
References
- UniProt :accession Q9UM73
- Atlas of genetics & cytogenetics in oncology & haematology
http://atlasgeneticsoncology.org/genes/ALK.html